PPTC7

Chr 12

protein phosphatase targeting COQ7

Also known as: TA-PP2C, TAPP2C

Enables protein serine/threonine phosphatase activity and protein-macromolecule adaptor activity. Involved in negative regulation of mitophagy and positive regulation of ubiquinone biosynthetic process. Located in mitochondrial matrix. Is active in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
9
Pubs (1 yr)
P/LP submissions
P/LP missense
0.36
LOEUF
LOF
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.36LOEUF
pLI 0.938
Z-score 3.12
OE 0.08 (0.030.36)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.89Z-score
OE missense 0.39 (0.320.48)
70 obs / 178.6 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.08 (0.030.36)
00.351.4
Missense OE?0.39 (0.320.48)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 1 / 13.2Missense obs/exp: 70 / 178.6Syn Z: 0.32

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PPTC7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →